Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,736,502
+$453,861 QoQ
Shares Held
69,837
-1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.71%
of 13F equity value
Holder Rank
#798
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AUXIER ASSET MANAGEMENT LLC holds $26,865,861 across 7 Drug Manufacturers - General names. JNJ ranks #1 (66.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
69,837 | $17,736,502 | |
| 2 | AMGN |
Amgen Inc
|
8,785 | $3,181,224 | |
| 3 | PFE |
Pfizer Inc
|
60,974 | $1,468,253 | |
| 4 | GSK |
GSK plc
|
27,181 | $1,424,828 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
21,671 | $1,248,683 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
8,611 | $1,087,913 | |
| 7 | LLY |
ELI LILLY & Co
|
599 | $718,458 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,736,502 | 69,837 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,282,641 | 70,703 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,640,677 | 70,745 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $13,318,347 | 71,828 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $11,018,774 | 72,136 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $12,001,674 | 72,369 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,479,309 | 72,461 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $11,768,959 | 72,621 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,637,378 | 72,779 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,805,719 | 74,630 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $11,838,885 | 75,532 | Shares | Sole | 2024-02-22 | |
| 2023-09-30 | $11,878,273 | 76,265 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $13,120,108 | 79,266 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $12,210,125 | 78,775 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $13,564,953 | 76,790 | Shares | Sole | 2023-02-17 | |
| 2022-09-30 | $12,554,216 | 76,850 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $14,009,266 | 78,921 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,253,013 | 80,421 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $14,265,527 | 83,390 | Shares | Sole | 2022-03-01 | |
| 2021-09-30 | $13,823,592 | 85,595 | Shares | Sole | 2021-11-18 | |
| 2021-06-30 | $14,131,891 | 85,783 | Shares | Sole | 2021-08-18 | |
| 2021-03-31 | $14,751,727 | 89,758 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $14,156,016 | 89,948 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $13,431,209 | 90,215 | Shares | Sole | 2021-03-05 | |
| 2020-06-30 | $12,721,389 | 90,460 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $12,208,203 | 93,100 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||